Susquehanna lowered the firm’s price target on Accenture (ACN) to $270 from $330 and keeps a Neutral rating on the shares. The firm said industry-related checks this quarter, and some of the commentary on the Consulting side, has sounded better recently. Consulting is the lifeblood of confidence at Accenture, and Susquehanna thinks it will show. But they will be on the sidelines unless and until Accenture can prove it this year.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN:
- Accenture: Buy Rating Maintained Despite Short-Term Challenges and Adjusted Price Target
- Accenture price target lowered to $305 from $335 at Guggenheim
- Accenture price target lowered to $350 from $372 at Baird
- Accenture price target lowered to $315 from $355 at Stifel
- AI Isn’t Dead – It’s Evolving from the Brains to the Body